This resource center was created to address the lack of nationally available human papillomavirus (HPV) and cervical cancer prevention information and resources. The center is dedicated to addressing the multiple issues and challenges associated …

This issue brief examines screening in the era of HPV vaccination and provides the latest evidence on new screening and treatment modalities for developing countries. It summarizes the current evidence on various options, namely cervical cytology …

Despite advances in prevention and treatment, AIDS, tuberculosis, and cervical cancer remain among the most serious and costly threats to world health. This article, published by the Population Reference Bureau, outlines the potential impact of …

This book provides physicians, nurses, nurse practitioners, physician assistants, pharmacists, and others with the most comprehensive information on vaccine-preventable diseases. In addition to chapters on more general vaccine-related topics, it …

This analysis, published in The Open Vaccine Journal, describes the policy environment related to human papillomavirus (HPV) vaccine introduction, identifies the policy processes and key stakeholders in HPV vaccine introduction, summarizes specific …

Several vaccines that have come to market, including the rotavirus, pneumococcal conjugate, and human papillomavirus vaccines, have the potential to bring large public health benefits to developing countries. This eight-page policy brief explains …

This report assesses global readiness to fight cervical cancer using new approaches and new technologies, especially in regions where the disease is a common killer. It underscores the urgent need for the global community to prioritize cervical …

This issue of Outlook provides information on opportunities for preventing cervical cancer through vaccination and screening. It summarizes evidence on the safety and efficacy of human papillomavirus vaccines as well as successful approaches for …

These pre-formatted PubMed searches will retrieve journal citations and available abstracts on cervical cancer and human papillomavirus, as well as specifically for Africa and Asia. Documents may be ordered through Loansome Doc if you have …

This fact sheet summarizes evidence published since 2009 on cervical cancer screening and treatment approaches for both low- and high-resource settings. The information provided supports the use of human papillomavirus DNA technologies …

This report summarizes results from a survey which obtained input from stakeholders within the Expanded Programme on Immunization in Vietnam about issues and perceptions related to the storage, distribution, and delivery of the current and potential …

This website is designed to provide easy access to science-based information for health program managers and decision-makers seeking to prevent cervical cancer in developing countries and low-resource settings. The wide range of materials appearing …

This report summarizes results from formative research in two states of India—Andhra Pradesh and Gujarat—regarding the health systems and policy context that will affect human papillomavirus (HPV) vaccine introduction, as well as …

This report summarizes results from formative research in Peru regarding the health systems and policy context that will affect human papillomavirus (HPV) vaccine introduction, as well as beliefs, values, attitudes, knowledge, and behaviors related …

This report summarizes results from formative research in Uganda regarding the health systems and policy context that will affect human papillomavirus (HPV) vaccine introduction, as well as beliefs, values, attitudes, knowledge, and behaviors …

This report summarizes results from formative research in Vietnam regarding the health systems and policy context that will affect human papillomavirus (HPV) vaccine introduction, as well as beliefs, values, attitudes, knowledge, and behaviors …

This document analyzes research and development activities for vaccines against infectious diseases of public health importance. Disease groups covered include diarrheal disease, sexually transmitted diseases, respiratory infections, bacterial …

From 2006 to 2011, PATH conducted demonstration projects in four low- and middle-income countries—India, Peru, Uganda, and Vietnam—to provide evidence for decision-making about public-sector introduction of human papillomavirus (HPV) …

Developing strategies to effectively reach adolescent girls with HPV vaccines—a population not typically the focus of public health programs—is essential to achieving high coverage rates and reducing the cervical cancer burden. This …

These documents provide the latest stability data for commonly used vaccines and current research on vaccine formulations and platform technologies. Data are sorted by vaccine in a table format in both documents.

This web page contains real-life accounts of people who have suffered or died from vaccine-preventable diseases, including compelling personal testimonies, remembrances, case reports, and newspaper articles.

This website is a comprehensive and user-friendly source of scientifically accurate and easily navigable immunization information. The site offers parents, other adults, legislators, the media, and others a one-stop shop for learning about vaccines …

The mission of the World Health Organization (WHO) global human papillomavirus (HPV) Laboratory Network (LabNet) is to contribute to improving quality of laboratory services for effective surveillance and monitoring of HPV vaccination impact, …

This web page provides links to information sheets on reaction rates of selected vaccines. The papers are primarily designed for use by national public health officials and immunization program managers. Data from these sheets can be used for the …

This information center was developed to accelerate the development and introduction of prophylactic HPV vaccines in countries with the highest burden of cervical cancer and reduce the incidence of this disease and related lesions among women. It …